Emerging paradigms in targeted treatments for Asian patients with NSCLC.
about
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterationsThe changing landscape of clinical trial and approval processes in China.Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes.
P2860
Emerging paradigms in targeted treatments for Asian patients with NSCLC.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging paradigms in targeted treatments for Asian patients with NSCLC.
@en
type
label
Emerging paradigms in targeted treatments for Asian patients with NSCLC.
@en
prefLabel
Emerging paradigms in targeted treatments for Asian patients with NSCLC.
@en
P2093
P2860
P1476
Emerging paradigms in targeted treatments for Asian patients with NSCLC.
@en
P2093
P2860
P304
P356
10.1517/14656566.2015.1040391
P407
P577
2015-04-23T00:00:00Z